Irina Rivkind Koffler analyst LIFESCI

Covered Stocks

Irina Rivkind Koffler

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Irina Rivkind Koffler works at LIFESCI and is focused on the Healthcare sector with 532 price targets and ratings documented since 2013 spanning on 2 stocks. Previously, Irina Rivkind Koffler worked at MIZUHO. Analyst's average stock valuation to be materialised ratio is 65.12% with an average time for price targets to be met of 243.94 days.

Most recent stock forecast was given on MNK, at 06-Aug-2019.

Irina Rivkind Koffler best performing recommendations are on DRRX (DURECT CORPORATION).
The best stock recommendation documented was for EGRX (EAGLE PHARMACEUTICALS, INC) at 1/9/2017. The price target of $64 was fulfilled within 2 days with a profit of $4.1 (6.02%) receiving and performance score of 30.1.

Average potential price target upside

Currently, out of the existing stock ratings of Irina Rivkind Koffler - 265 which are a Hold (41.93%), 323 which are a Buy (51.11%), 44 which are a Sell (6.96%)

DRRX LGND

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

32

$27.68 (640.74%)

3 months 24 days ago

0/1 (0%)

$27.96 (692.08%)

Buy

8

$2.62 (48.70%)

8

1 years 10 months 26 days ago

6/6 (100%)

$-12.28 (-61.00%)

371

Buy

2 years 10 months 4 days ago

2/2 (100%)

$1.77 (181.60%)

845

Buy

50

2 years 10 months 19 days ago

0/4 (0%)

$26.19 (112.85%)

Buy

30

$25.68 (594.44%)

30

7 years 9 months 7 days ago

5/5 (100%)

$5.16 (31.85%)

354

Show more analysts
DRRX LGND